RSS Feeds
Five Years' Treatment of Parkinson's Disease with Levodopa
Therapeutic Results and Survival of 100 Patients
Abstract
One hundred patients with Parkinson's disease, who started taking levodopa before the end of 1968, have been assessed after 5 years. Forty-seven patients are still being followed on levodopa, and half of them are at least 25% better than at their pretreatment evaluation. However, the average functional rating is returning toward baseline from its remarkable improvement at ½ to 2 years. Abnormal involuntary movements, rapid oscillations in motor performance, postural instability, and dementia have become the major adverse effects. Thirty-two of the 100 patients have died. Life-table analysis shows an excess mortality of 1.9 compared with the U. S. population, a figure that is lower than the 2.9 reported before levodopa's use. Despite its inability to cure Parkinson's disease, levodopa provides symptomatic relief for a prolonged time and it remains the single most effective medication for the illness.
Article and Author Information
-
▸From the Department of Neurology, Cornell University Medical College, New York, New York.
-
Grant support: grants from the American Parkinson's Disease Association, Hoffmann LaRoche, Inc., and the General Clinical Research Centers Program of the Division of Research Resources, National Institutes of Health (RR-47).
-
łRequests for reprints should be addressed to Richard D. Sweet, M.D., Department of Neurology, Cornell University Medical College, New York Hospital, 525 East 68 Street, New York, NY 10021.
-
- Received January 31, 1975.
- Accepted June 20, 1975.
Related Clinical Content
